Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591772 · ClinicalTrials.gov registry record
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 36
- Enrollment target
NCT01591772: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01591772 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01591772 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about possible changes in brain anatomy and function, and in thinking abilities, such as memory skills, in patients with ovarian cancer who receive treatment with chemotherapy. Cancer patients treated with chemotherapy may experience changes in thinking abilities, and these may interfere with quality of life. Most of the research to date has involved patients with breast cancer, and there are no studies in women with ovarian cancer looking at at treatment-related changes in brain anatomy and function.
Interventions
- OTHER Neuroimaging & Neuropsychological Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-04-24 |
| Est. Completion | 2022-05-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01591772
The ClinicalTrials.gov registry entry for NCT01591772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuroimaging & Neuropsychological Evaluation is the first listed.
NCT01591772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01591772 about?
NCT01591772 is a clinical study titled "Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer". The purpose of this study is to learn about possible changes in brain anatomy and function, and in thinking abilities, such as memory skills, in patients with ovarian cancer who receive treatment with chemotherapy. Cancer patients treated with chemotherapy may experience changes in thinking abilitie...
What is the current status of trial NCT01591772?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2012-04-24. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT01591772?
The interventions under investigation include: Neuroimaging & Neuropsychological Evaluation (OTHER).
Who is sponsoring clinical trial NCT01591772?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.